Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.
Journal: The New England journal of medicine
Published: February 18, 2026
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.
Journal: The New England journal of medicine
Published: February 18, 2026
The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
Journal: Annals of internal medicine
Published: April 29, 2024
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Journal: NEJM evidence
Published: May 22, 2023
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.
Journal: Open forum infectious diseases
Published: August 19, 2021
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
Journal: The Journal of infectious diseases
Published: July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
Journal: The Journal of infectious diseases
Published: July 10, 2020
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination.
Journal: HIV research & clinical practice
Published: March 13, 2020
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 25, 2019
Screening and Enrollment by Sex in Human Immunodeficiency Virus Clinical Trials in the United States.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 11, 2019
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
Journal: AIDS research and human retroviruses
Published: May 18, 2019
Last Updated: 09/26/2026